Merck Gets CHMP Backing of Keytruda in Malignant Pleural Mesothelioma
The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...
FiercePharma8h
Fierce Pharma Asia—Merck and BioNTech's I-O bispecific buys; AZ CEO's China defense
VEGF bispecifics. | Merck and BioNTech are buying Chinese biotechs to gain PD-(L)1/VEGF bispecifics. AstraZeneca's CEO argued ...
Wolfe starts Merck at Peer Perform, notes competitive overhangs
Wolfe Research initiated coverage of Merck (MRK) with a Peer Perform rating. The firm said the main sentiment driver for Merck is ...
Is Merck Stock a Buy?
With its portfolio of cancer medicines and one of the pharma industry's most recognizable names, it's no surprise that investors are curious about whether to buy shares of Merck (NYSE: MRK). But with ...
Ad Age18d
Merck—ad spending, facts and profile
Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...
Yahoo Finance19d
Merck & Co., Inc. (MRK): Among the Best Dow Stocks to Buy According to Analysts
We recently compiled a list of the 9 Best Dow Stocks to Buy According to Analysts. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other Dow ...
Insider Monkey19d
Merck & Co., Inc. (MRK): Among the Best Stocks to Buy for High Returns in 2024
We recently compiled a list of the 8 Best Stocks to Buy for High Returns in 2024. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other ...
Yahoo Finance19d
Merck & Co., Inc. (MRK): Among the Best Stocks to Buy for High Returns in 2024
We recently compiled a list of the 8 Best Stocks to Buy for High Returns in 2024. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks to ...
Where Will Merck Be in 5 Years?
This year, pharmaceutical giant Merck (NYSE: MRK) is it: The drugmaker's shares are down by 2% in 2024 while the broader S&P ...
AOL21d
Where Will Merck Be in 5 Years?
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Merck wasn’t one of them. The 10 stocks that made the cut ...
The Motley Fool21d
Where Will Merck Be in 5 Years?
Merck will face an important patent cliff by the end of the decade. The company has a plan to move beyond it. Competition from a new therapy shouldn't derail Merck's prospects. Even when we zoom ...
Nasdaq21d
Merck to Report Q3 Earnings: To Buy or Not to Buy MRK Stock?
Merck has an Earnings ESP of -2.32% and a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Per our proven model, companies with the ...